Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.

Whitsett TG, Mittal SK, Eschbacher JM, Carson VM, Smith MA, Bremner RM, Inge LJ.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1891-1899. doi: 10.1016/j.jtcvs.2017.11.067. Epub 2017 Dec 23.

PMID:
29370903
2.

WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer.

Richer AL, Cala JM, O'Brien K, Carson VM, Inge LJ, Whitsett TG.

Cancer Res. 2017 Sep 1;77(17):4663-4672. doi: 10.1158/0008-5472.CAN-16-3565. Epub 2017 Jun 26.

PMID:
28652249
3.

Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR.

Richer AL, Friel JM, Carson VM, Inge LJ, Whitsett TG.

Pharmgenomics Pers Med. 2015 Feb 20;8:63-79. doi: 10.2147/PGPM.S52845. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center